Sorrento Therapeutics Funding & Investors
San Diego, CA
Sorrento Therapeutics, Inc. is a biopharmaceutical company. The Company researches human therapeutic antibodies for the treatment of cancer, inflammation, metabolic, and infectious diseases.
sorrentotherapeutics.comTotal Amount Raised: $264,418,496
Sorrento Therapeutics Funding Rounds
Post Ipo Equity
$25,000,000
Post Ipo Debt
$75,000,000
Post Ipo Equity
$150,000,000
Post Ipo Equity Investors
Ally Bridge GroupPost Ipo Debt
$1,850,000
Debt Financing
$1,850,000
Post Ipo Equity
$6,418,495
IPO
Unknown
Post Ipo Equity
$2,000,000
Series Unknown
$2,300,000
Funding info provided by Diffbot.